Viseven: How Pharma Giants Are Winning HCP Mindshare with Next-Gen Omnichannel
Feature Categories
What is Viseven?
Viseven is a specialised MarTech services and AI content platform provider for the life sciences and pharma industries. Its flagship eWizard platform empowers teams to build modular, compliant, and omnichannel content workflows—automating content creation, localisation, tagging, and regulatory review processes.
AI agents like eVa assist with real‑time, brand‑safe copy generation and regulatory alignment, speeding up MLR approval by approximately 45% and reducing content production costs by approximately 50%. As a trusted partner to enterprise pharma and biotechs, Viseven enables omnichannel storytelling via email, portals, video avatars, and mobile apps while ensuring consistent messaging across global and local markets.
Their services support scalable digital transformation across marketing, medical affairs, and sales enablement.
Why Leading Healthcare Teams Trust Viseven
-
Recognized Excellence in Pharma Marketing
Viseven was named Best Pharma & Life Sciences Marketing Agency 2025 by Corporate Vision Magazine, underscoring its leadership in the industry. -
Award-Winning Innovation
The company’s content experience platform, eWizard, won Gold at the 2025 Globee® Awards for Most Innovative Product of the Year, highlighting its cutting-edge solutions. -
Global Presence with Extensive Expertise
With over 700 professionals and more than 15 years of experience, Viseven has partnered with over 150 pharma and life sciences clients and collaborated with more than 250 agencies worldwide. -
Strategic Partnerships with Industry Leaders
Viseven has established partnerships with leading technology companies, including SpotMe, Aprimo, and Creatio, to offer seamless integrations and create digital ecosystems for streamlined workflows and accelerated collaboration. -
Innovative AI-Driven Solutions
The introduction of eVa, an AI agent for the eWizard platform, revolutionizes how marketing and medical teams create, adapt, and validate content by automating complex workflows and significantly accelerating the Medical-Legal-Review (MLR) process. -
Active Participation in Industry Events
Viseven actively participates in major industry events such as Digital Pharma East, Reuters Pharma EU, and Pharma IT & Digital Health Expo, showcasing its commitment to staying at the forefront of digital transformation in the pharmaceutical sector. -
Commitment to Digital Transformation
Celebrating its 15th anniversary in 2024, Viseven continues to evolve and innovate, reflecting its dedication to transforming the pharmaceutical marketing landscape.
Features
Top 3 Pain Points Viseven Fixes in Healthcare
| Problem | How Viseven Solves It |
|---|---|
| 1. Slow, manual content creation and MLR approval | AI agent (eVa) auto-generates compliant content, streamlines workflows, and speeds approval cycles by 45% |
| 2. Fragmented and inconsistent messaging across markets | Modular asset reuse and localization across channels via eWizard platform ensure consistent quality and branding globally |
| 3. High content production cost and low reusability | AI auto-tagging, structured metadata, and modularization reduce cost by up to 50% and boost reusability by 30%+ |
Feature Category Summary: Viseven
| Feature Category | Summary |
|---|---|
| Regulatory-Ready | No focus on regulatory compliance or validation for clinical or trial software. |
| Clinical Trial Support | Not designed to support clinical trial design, recruitment, or monitoring. |
| Supply Chain & Quality | No supply chain management or quality assurance features. |
| Efficiency & Cost-Saving | Automates pharma digital marketing workflows, reducing costs and streamlining processes. |
| Scalable / Enterprise-Grade | Proven SaaS solution used by leading global pharma enterprises. |
| HIPAA Compliant | No explicit HIPAA compliance focus, not managing protected health data. |
| Clinically Validated | Not clinically validated for medical use; marketing-focused tool. |
| EHR Integration | Does not integrate with EHR or clinical systems. |
| Explainable AI | AI is used for marketing automation; transparency in clinical decision AI is not applicable. |
| Real-Time Analytics | Provides real-time analytics and reporting related to content and marketing performance. |
Risks & Limitations: Viseven
-
Effectiveness depends on the quality and completeness of input content and metadata; poor assets or inconsistent tagging reduce AI relevance and recommendation accuracy.
-
Outputs are decision-support only; marketing/medical communications teams must review and approve AI-generated content before distribution.
-
Integration with CRM, MLR (medical-legal-review) workflows, content management systems or vendor-specific platforms may require IT effort and custom connectors.
-
Regulatory and compliance review may be needed when AI-assisted content informs promotional materials, patient communications, or clinical trial outreach; maintain audit trails and MLR signoffs.
-
Localisation and medical accuracy risks: automated translations/simplifications can introduce clinical nuance errors—local medical review is required for regional markets.
-
Model drift and content-relevance decay can occur as product labels, guidelines or therapeutic context change—plan for periodic retraining and content refresh.
-
Privacy & data governance: processing patient-level or PHI-adjacent content requires robust controls, consent workflows, and data residency considerations.
-
Overreliance on templates or automation can reduce creative quality or contextual appropriateness; human editorial oversight remains essential.
Share This AI Tool
Contact Us To Request Pricing or a Demo
